metricas
covid
Gastroenterología y Hepatología (English Edition) Efficacy and safety of rifaximin associated with standard triple therapy (omepra...
Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial
Eficacia y seguridad de la rifaximina asociada a la triple terapia estándar (omeprazol, claritromicina y amixicilina) para la erradicación de H. pylori: ensayo clínico piloto fase IV
Mercedes Ramasa,b, Maria G. Dondaya,b, Adrian G. McNicholla,b, Javier P. Gisberta,b,
Corresponding author
javier.p.gisbert@gmail.com

Corresponding author.
a Servicio Aparato Digestivo, Hospital Universitario de La Princesa and Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain
b Universidad Autónoma de Madrid and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain
Read
4329
Times
was read the article
610
Total PDF
3719
Total HTML
Share statistics
Article information
ISSN: 24443824
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 100 13 113
2025 11 299 77 376
2025 10 180 6 186
2025 9 183 18 201
2025 8 146 10 156
2025 7 191 12 203
2025 6 104 5 109
2025 5 57 6 63
2025 4 58 3 61
2025 3 95 2 97
2025 2 45 4 49
2025 1 46 6 52
2024 12 36 6 42
2024 11 29 5 34
2024 10 33 8 41
2024 9 40 8 48
2024 8 30 5 35
2024 7 26 5 31
2024 6 32 1 33
2024 5 42 6 48
2024 4 23 3 26
2024 3 40 5 45
2024 2 19 2 21
2024 1 28 3 31
2023 12 21 2 23
2023 11 34 6 40
2023 10 26 4 30
2023 9 21 1 22
2023 8 36 2 38
2023 7 13 3 16
2023 6 23 2 25
2023 5 43 2 45
2023 4 66 5 71
2023 3 37 4 41
2023 2 40 5 45
2023 1 64 3 67
2022 12 42 12 54
2022 11 50 16 66
2022 10 77 14 91
2022 9 42 12 54
2022 8 55 10 65
2022 7 37 11 48
2022 6 57 6 63
2022 5 61 14 75
2022 4 80 15 95
2022 3 127 7 134
2022 2 115 8 123
2022 1 99 9 108
2021 12 64 14 78
2021 11 55 6 61
2021 10 40 11 51
2021 9 32 13 45
2021 8 29 12 41
2021 7 14 11 25
2021 6 17 19 36
2021 5 18 9 27
2021 4 47 10 57
2021 3 16 13 29
2021 2 19 5 24
2021 1 12 5 17
2020 12 14 7 21
2020 11 18 9 27
2020 10 13 6 19
2020 9 17 8 25
2020 8 20 7 27
2020 7 12 8 20
2020 6 13 8 21
2020 5 22 8 30
2020 4 20 1 21
2020 3 8 4 12
2020 2 16 3 19
2020 1 18 8 26
2019 12 16 13 29
2018 7 0 0 0
2018 6 1 0 1
Show all

Follow this link to access the full text of the article